LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Vintura joins EuropaBio: Creating meaningful impact for patients and health systems

    13/02/2025

    PRESS RELEASE

    Brussels, 13 February 2025 - EuropaBio is excited to announce that Vintura has joined the association.

    Founded in 2000, Vintura is a strategy consultancy dedicated to life sciences and healthcare. Its mission is to create meaningful impact for patients and health systems. With offices in the Netherlands, the UK, Germany and France, Vintura is a leading worldwide provider of holistic solutions for pharma and biotech, as well as care providers, payers and policy makers.

    In joining EuropaBio, Vintura will further strengthen their network in the European biopharma industry whilst contributing to the dialogue around building a competitive and patient-centred healthcare ecosystem.

    Dr. Claire Skentelbery, Director General of EuropaBio said “Vintura brings a valuable voice for the role of patients and innovation within robust health systems. We have to bring all stakeholders together for Europe’s healthy future and we are delighted that Vintura helps build advocacy strength.”

    Casper Paardekooper, Partner & Board Member at Vintura had this to say "We are excited to join EuropaBio, as we have very aligned missions. With a large number of EU policy changes happening (EU HTA, GPL, Biotech Act), it is critical to strategically prepare and collaborate.”

    For more information on Vintura, please visit vintura.com

    Vintura joins EuropaBio: Creating meaningful impact for patients and health systems


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    18/05/2026

    Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force


    Read more
    12/05/2026

    ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act


    Read more
    08/05/2026

    Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology


    Read more

    Important links

    • Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force
    • ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.